IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2016 Holdings

Filed 2016-08-12 | 20 holdings | $16.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$15.7M329,14298.4%
United Therapeutics Corp(UTHR)COM91307C102$29.2K275,2480.2%
Orthofix International NVCOMN6748L102$27.4K646,4460.2%
Impax Laboratories IncCOM45256B101$21.1K730,8170.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$20.0K906,9300.1%
Teva Pharmaceutical(TEVA)COM881624209$19.9K396,5450.1%
Amgen IncCOM31162100$19.1K125,8020.1%
Halyard Health IncCOM40650V100$18.7K575,2060.1%
Sucampo PharmaceuticalsCOM864909106$17.9K1,631,3980.1%
Indivior PLCCOMG4766E108$15.8K4,727,9700.1%
Merck & Co. Inc.(MRK)COM58933Y105$14.8K257,5380.1%
RTI Surgical IncCOM74975N105$13.1K3,648,0010.1%
Shire PLCCOM82481R106$11.6K63,1660.1%
Invacare CorpCOM461203101$10.9K901,4400.1%
Allergan PLCCOMG0177J108$6.1K26,4160.0%
Depomed IncCOM249908104$4.3K217,9040.0%
Aviragen Therapeutics IncCOM53761102$3.8K2,708,4380.0%
Derma Sciences IncCOM249827502$3.6K910,7030.0%
Digirad CorpCOM253827109$2.5K481,2180.0%
Juniper Pharmaceuticals IncCOM48203L107$2.0K287,7550.0%